美国的视网膜市场:季报

本报告提供视网膜市场中，每季实施对美国的视网膜的专家的调查，收集资料。将结果分析，每季反映的报告能正确评估、掌握，目前市场情形，以决策流程的改善为目的，含视网膜治疗，产品的使用与市场占有率，产品的采用计划，医生的医药品、手术器具的评估等。

各更新中，包含全年的预测，与上年度的比较，趋势分析。

一年4次，美国的视网膜市场上主要指标的检测、分析。

• 各疾病及各产品的玻璃体内 (IVT) 注射
• Eylea, Lucentis, Avastin, Macugen, Visudyne PDT的使用
• 糖尿病黄斑部水肿 (DME) 治疗
• 皮质类固醇的使用
• 光凝固数量和光凝固剂的使用
• 玻璃体切除的数量与位置
• 玻璃体切除机的使用与市场占有率
• 可重复使用、抛弃式的器具
• 视觉化剂

更新资讯中，包含过去数年收集资讯的比较为基础的趋势分析。还有包含美国的视网膜手术 (IVT注射)的全年预测，及与前一年的比较。

Our coverage of the US retina market includes a quarterly surveying process that targets and collects data from retina specialists. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Retina Editions. These editions are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including retinal patient care, product use and market share, product adoption plans, and doctors' evaluations of pharmaceuticals and surgical equipment.

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

Contents:

“The Ophthalmic Market Trends: Quarterly US Retina Editions ” measure and analyze key metrics of the US retinal market four times per year, including:

• IVT injections by disease and product;
• Use of Eylea, Lucentis, Avastin, Macugen, and Visudyne PDT;
• DME treatments;
• Corticosteroid use;
• Photocoagulation volume and photocoagulators used;
• Vitrectomy volume and location;
• Vitrectomy machine use and market share;
• Reusable and disposable instruments.
• Visualization agents

Our updates include trend analysis based on comparisons with information gathered in previous years. We also provide a full-year forecast for US retinal procedures (including IVT injections) and a comparison with volumes during the prior year.